Assessment of PD-L1 mRNA expression in gastrointestinal tumors and the response to immunotherapy

BACKGROUND: Programmed death ligand 1 (PD-L1) immunohistochemistry (IHC) has been proposed as a predictive biomarker to predict response to immunotherapy. Given the limitations of IHC test in PD-L1 detection, this study aimed to investigate the technical feasibility of using quantitative RT-PCR (qRT...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Qingqing, Li, Jieyi, Chen, Qiaofeng, Zhao, Xiaokai, Zhou, Ru, Zhang, Wenpeng, Gong, Ziying, Zhang, Daoyun, Wang, Mingliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751311/
https://www.ncbi.nlm.nih.gov/pubmed/36530975
http://dx.doi.org/10.3389/fonc.2022.926746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751311/
https://www.ncbi.nlm.nih.gov/pubmed/36530975
http://dx.doi.org/10.3389/fonc.2022.926746

Ejemplares similares